Dark

Check out our Dark Pool Levels

ALPN
Alpine Immune Sciences, Inc. Common Stock
stock NASDAQ

Inactive

May 17, 2024

64.97USD+0.015%(+0.01)4,282,048

Pre-market

0.00USD-100.000%(-64.96)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsTrends

ALPN Reddit Mentions

Subreddits

Limit Labels Price

We have sentiment values and mention counts going back to 2017. The complete data set is available via the API.

Take me to the API

ALPN Specific Mentions

As of Jul 30, 2026 12:56:48 AM EDT (1 min. ago)

Includes all comments and posts. Mentions per user per ticker capped at one per hour.

98 days ago • u/rman712 • r/biotech_stocks • 2026_pdufa_adcom_tracker_ive_been_maintaining_13 • C

Really appreciate this. will counter-check before adding. On first pass:
* SRPT Elevidys expansion (Jun 14) and MRK patritumab deruxtecan (Jun 16) both look plausible. SRPT has had staggered label-expansion activity; MRK/Daiichi patritumab had a 2024 CRL for manufacturing and a resubmission would roughly line up with a June 2026 date. Will be checking with Sarepta + Merck IR.
* BMTX B-VEC eye drops — BMTX is BM Technologies (fintech). B-VEC is Krystal Biotech, ticker KRYS. Looks like Gemini swapped tickers. Gotta see whether Krystal has an ocular-indication PDUFA in that window.
* ALPN povetacicept — Alpine Immune was acquired by Vertex (VRTX) in 2024, so ALPN isn't a standalone anymore. Povetacicept is now in VRTX's pipeline. If there's a 2026 PDUFA, it'd be under VRTX.
Will update the post once I've verified. Thanks for the prod.

98 days ago • u/rman712 • r/biotech_stocks • 2026_pdufa_adcom_tracker_ive_been_maintaining_13 • C

Really appreciate this. will counter-check before adding. On first pass:
* SRPT Elevidys expansion (Jun 14) and MRK patritumab deruxtecan (Jun 16) both look plausible. SRPT has had staggered label-expansion activity; MRK/Daiichi patritumab had a 2024 CRL for manufacturing and a resubmission would roughly line up with a June 2026 date. Will be checking with Sarepta + Merck IR.
* BMTX B-VEC eye drops — BMTX is BM Technologies (fintech). B-VEC is Krystal Biotech, ticker KRYS. Looks like Gemini swapped tickers. Gotta see whether Krystal has an ocular-indication PDUFA in that window.
* ALPN povetacicept — Alpine Immune was acquired by Vertex (VRTX) in 2024, so ALPN isn't a standalone anymore. Povetacicept is now in VRTX's pipeline. If there's a 2026 PDUFA, it'd be under VRTX.
Will update the post once I've verified. Thanks for the prod.

Share